Our preliminary data have shown that the POL I inhibitor CX-5461 induces a significant accumulation of cytosolic DNA, transcriptionally activates STING, and induces phosphorylation of IRF3, which induces type I IFN in ovarian cancer cells. Here, IRF3 is linked to ovarian carcinoma.